| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 25 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 16 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HPP5
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 96 | 100 | PF00656 | 0.569 |
| CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.554 |
| CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.413 |
| CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.377 |
| CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.389 |
| CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.295 |
| CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.544 |
| CLV_PCSK_PC1ET2_1 | 9 | 11 | PF00082 | 0.560 |
| CLV_Separin_Metazoa | 13 | 17 | PF03568 | 0.671 |
| DOC_MAPK_gen_1 | 38 | 44 | PF00069 | 0.580 |
| DOC_PP4_FxxP_1 | 70 | 73 | PF00568 | 0.491 |
| DOC_USP7_UBL2_3 | 28 | 32 | PF12436 | 0.662 |
| DOC_WW_Pin1_4 | 47 | 52 | PF00397 | 0.503 |
| LIG_APCC_ABBA_1 | 49 | 54 | PF00400 | 0.503 |
| LIG_FHA_2 | 32 | 38 | PF00498 | 0.613 |
| LIG_LIR_Gen_1 | 50 | 60 | PF02991 | 0.503 |
| LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.503 |
| LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.504 |
| LIG_SH3_4 | 72 | 79 | PF00018 | 0.503 |
| LIG_TRAF2_1 | 94 | 97 | PF00917 | 0.539 |
| MOD_CK1_1 | 78 | 84 | PF00069 | 0.491 |
| MOD_CK2_1 | 91 | 97 | PF00069 | 0.640 |
| MOD_GlcNHglycan | 64 | 68 | PF01048 | 0.335 |
| MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.291 |
| MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.546 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.569 |
| MOD_NEK2_1 | 14 | 19 | PF00069 | 0.603 |
| MOD_NEK2_1 | 23 | 28 | PF00069 | 0.599 |
| MOD_NEK2_2 | 19 | 24 | PF00069 | 0.567 |
| MOD_PIKK_1 | 1 | 7 | PF00454 | 0.553 |
| MOD_PIKK_1 | 78 | 84 | PF00454 | 0.516 |
| MOD_PKA_1 | 24 | 30 | PF00069 | 0.724 |
| MOD_PKA_2 | 23 | 29 | PF00069 | 0.581 |
| MOD_ProDKin_1 | 47 | 53 | PF00069 | 0.503 |
| MOD_SUMO_rev_2 | 33 | 40 | PF00179 | 0.543 |
| MOD_SUMO_rev_2 | 87 | 95 | PF00179 | 0.489 |
| TRG_ER_diArg_1 | 23 | 25 | PF00400 | 0.659 |
| TRG_ER_diArg_1 | 44 | 46 | PF00400 | 0.577 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HWY6 | Leptomonas seymouri | 96% | 100% |
| A0A0S4JL81 | Bodo saltans | 68% | 89% |
| A0A1X0P4U0 | Trypanosomatidae | 74% | 100% |
| A0A3S7XBD2 | Leishmania donovani | 98% | 100% |
| A0A422MZD2 | Trypanosoma rangeli | 73% | 100% |
| A2R091 | Aspergillus niger (strain CBS 513.88 / FGSC A1513) | 41% | 66% |
| A4ID19 | Leishmania infantum | 98% | 100% |
| D0A8G9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
| E9ATF9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |
| Q1DI23 | Coccidioides immitis (strain RS) | 44% | 66% |
| Q2H4X9 | Chaetomium globosum (strain ATCC 6205 / CBS 148.51 / DSM 1962 / NBRC 6347 / NRRL 1970) | 38% | 69% |
| Q4I283 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 39% | 67% |
| Q4Q138 | Leishmania major | 97% | 100% |
| Q54TR8 | Dictyostelium discoideum | 51% | 73% |
| Q7SDU4 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 39% | 68% |
| Q92371 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 34% | 68% |
| V5BE97 | Trypanosoma cruzi | 73% | 100% |